Related Experiment Videos
CD34: to select or not to select? That is the question
1Children's Hospital Los Angeles, Dept Pediatrics, University of Southern California School of Medicine, 90027, USA.
Leukemia
|May 10, 2000
Summary
A novel population of dormant, CD34-negative human hematopoietic stem cells has been discovered. This finding questions the standard CD34+ cell isolation method for stem cell transplantation.
Area of Science:
- Hematology
- Stem Cell Biology
- Immunology
Background:
- CD34 expression on the cell membrane is traditionally used as a marker for stem cell activity.
- Recent mouse studies revealed a quiescent stem cell population lacking CD34 but possessing full reconstituting capacity.
Purpose of the Study:
- To review the discovery of a similar CD34-negative dormant hematopoietic stem cell population in humans.
- To discuss the implications of this discovery for current stem cell transplantation protocols.
Main Methods:
- Review of recent scientific evidence and literature.
- Analysis of data pertaining to CD34 expression and hematopoietic stem cell function.
- Comparison of findings in mouse models with human stem cell populations.
Main Results:
- Identification of a dormant population of human hematopoietic stem cells that do not express CD34.
- Demonstration that CD34 negativity does not preclude stem cell activity or reconstituting capacity.
- Evidence suggests CD34 expression is not a definitive marker for all functional stem cells.
Conclusions:
- The existence of CD34-negative hematopoietic stem cells challenges the reliance on CD34+ cell isolation for stem cell transplantation.
- Further research is needed to fully understand the role and potential of this CD34-negative stem cell population.
- Future stem cell transplantation strategies may benefit from methods targeting mature blood cell lineages rather than CD34 expression.